GE HealthCare Files 8-K

Ticker: GEHC · Form: 8-K · Filed: 2025-06-09T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, 8-k, corporate-update

Related Tickers: GEHC

TL;DR

GE HealthCare filed an 8-K on 6/9/25, check for updates.

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on June 9, 2025, to report other events and financial statements. The filing does not contain specific financial figures or details about the nature of the 'other events' beyond its classification as a current report.

Why It Matters

This 8-K filing indicates GE HealthCare Technologies Inc. has submitted a current report to the SEC, which may contain material updates or events relevant to investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose specific material financial information or significant corporate actions.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 9, 2025.

What is the exact date of the report?

The date of the report is June 9, 2025.

What is the SEC File Number for GE HealthCare Technologies Inc.?

The SEC File Number is 001-41528.

Where are GE HealthCare Technologies Inc.'s principal executive offices located?

The principal executive offices are located at 500 W. Monroe Street, Chicago, IL 60661.

Does this filing provide specific financial details or material event descriptions?

No, this filing is a general current report and does not provide specific financial figures or detailed descriptions of the 'other events' within the provided text.

From the Filing

0001932393-25-000041.txt : 20250609 0001932393-25-000041.hdr.sgml : 20250609 20250609160702 ACCESSION NUMBER: 0001932393-25-000041 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250609 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250609 DATE AS OF CHANGE: 20250609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 251034095 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 gehc-20250609.htm 8-K gehc-20250609 0001932393 false 0001932393 2025-06-09 2025-06-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 9, 2025 GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)   Delaware 001-41528 88-2515116 (State or other jurisdiction of incorporation) (Commission  File Number) (IRS Employer Identification No.)       500 W. Monroe Street, Chicago, IL   60661 (Address of principal executive offices)   (Zip Code)         (Registrant’s telephone number, including area code) ( 833 ) 735-1139 ______________________________________________ (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.01 per share GEHC The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01 Other Events. On June 9, 2025, GE HealthCare Technologies Inc. (the “Company”) issued $650,000,000 aggregate principal amount of 4.800% Senior Notes due January 15, 2031 (the “2031 Notes”) and $850,000,000 aggregate principal amount of 5.500% Senior Notes due June 15, 2035 (the “2035 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to its effective shelf registration statement on Form S-3 (File No. 333-280584). Interest on the 2031 Notes will be payable on January 15 and July 15 of each year, beginning on January 15, 2026, and interest on the 2035 Notes will be pa

View on Read The Filing